Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease

Check out this “hot off the press” article Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long‐acting beta2‐agonists (https://onlinelibrary.wiley.com/doi/10.1002/pds.5432) and the related earlier article No Evidence of Off-label Use of Olodaterol and Indacaterol in Denmark, France, and the Netherlands: A Drug Utilization Study (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968970/) with coauthors from SIGMA members Aarhus University, PHARMO Institute for Drug Outcomes Research and RTI Health Solutions.

https://onlinelibrary.wiley.com/doi/10.1002/pds.5432

Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacroli

We are excited to share the newest article on the Protopic® JOint European Longitudinal Lymphoma and skin cancer Evaluation (JOELLE) study with SIGMA members and collaborators at RTI Health Solutions, PHARMO Institute for Drug Outcomes Research, Syddansk Universitet - University of Southern Denmark and Karolinska Institutet among other coauthors.

The study acronym JOELLE was chosen to honor Dr. Joelle Erkens, pharmacoepidemiologist at Astellas and formerly at PHARMO Institute, who was lost to the research team in June 2011 upon her untimely death.

https://www.dovepress.com/long-term-risk-of-skin-cancer-and-lymphoma-in-users-of-topical-tacroli-peer-reviewed-fulltext-article-CLEP

Overview of the European post-authorisation study registerpost-authorization studies performed in Europe fromSeptember 2010 to December 2018

Take a look at this interesting new article with an overview of the studies registered in the EU PAS Register from September 2010 to December 2018.

This initiative was led by the ENCePP Working Group 3, including SIGMA members and collaborators Agenzia regionale di sanità della Toscana, Health - Aarhus University, Bordeaux PharmacoEpi, RTI Health Solutions, UMC Utrecht, and Università degli Studi di Verona among other coauthors:

https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.5413

Where to begin? Thirty must‐read papers for newcomers to pharmacoepidemiology

Don't miss this great article by SIGMA members Syddansk Universitet - University of Southern Denmark’s Anton Pottegård and Jesper Hallas and RTI Health Solutions's Susana Perez-Gutthann, et al. 

https://onlinelibrary.wiley.com/doi/10.1002/pds.5382

The SIGMA consortium at ISPE’s 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management

The SIGMA consortium was presented virtually at ISPE’s 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2021 All Access) held August 23-25 2021.

The presented poster can be found here: